Mark Shapiro

2.0k citations
43 papers · 1.6k · h-index 21

Impact in

  • Hematology top 5%
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 5%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Chronic Myeloid Leukemia Treatments 13
    • Chronic Lymphocytic Leukemia Research 9

Mark Shapiro

41 papers receiving 1.5k citations

Peers

Mark Shapiro
Comparison fields: 5 of 87
  • Hematology 376
  • Genetics 286
  • Pulmonary and Respiratory Medicine 483
  • Oncology 391
  • Microbiology 11
Replace Patrice Berthaud with:
Patrice Berthaud France
Felicitas Hitz Switzerland
Bruno Audhuy France
Deok‐Hwan Yang South Korea
Donald A. Vena United States
Jeffrey Margolis United States
Peter Bojko Germany
Mars B. van ’t Veer Netherlands
H.‐G. Mergenthaler Germany
Maurizio Miglino Italy
Mark Shapiro relative to Patrice Berthaud France Patrice Berthaud's profile →
Citations per field
00.5×2×4×6×7×
Patrice Berthaud · 1×
Citations per year

Countries citing papers authored by Mark Shapiro

Since Specialization
Citations

This map shows the geographic impact of Mark Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shapiro more than expected).

Fields of papers citing papers by Mark Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shapiro. The network helps show where Mark Shapiro may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Shapiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Shapiro Line = papers co-authored together Mark Shapiro links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2010284
2 2010167
3 2009121
4 201191
5 201677
6 201371
7 201571
8 201560
9 201858
10 195350
11 201245
12 201537
13 201634
14 200833
15 201431
16 200829
17 200826
18 201626
19 201225
20 200624

About Mark Shapiro

Mark Shapiro is a scholar working on Hematology, Genetics, Oncology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 43 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (9 papers), Lung Cancer Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Eosinophilic Disorders and Syndromes (4 papers), CAR-T cell therapy research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (376 citations), Genetics (286 citations), Pulmonary and Respiratory Medicine (483 citations), Oncology (391 citations) and Microbiology (11 citations). Mark Shapiro has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Juan P. Wisnivesky, Cynthia S. Chin, Steven Swanson, Todd S. Weiser, Jörge E. Cortes, Robert J. Korst, Cameron D. Wright, Shubin Sheng, Hagop Kantarjian and Carlo B Gambacorti-Passerini. Their work appears in journals such as Blood, The Annals of Thoracic Surgery, Journal of Clinical Oncology, American Journal of Hematology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact